Amit Gupta Sells 5,964 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 5,964 shares of Cardlytics stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total transaction of $21,887.88. Following the transaction, the chief executive officer now directly owns 186,904 shares in the company, valued at $685,937.68. The trade was a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Amit Gupta also recently made the following trade(s):

  • On Thursday, October 24th, Amit Gupta sold 22,607 shares of Cardlytics stock. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95.

Cardlytics Trading Down 1.4 %

NASDAQ CDLX opened at $3.44 on Wednesday. The company has a market cap of $174.83 million, a PE ratio of -0.56 and a beta of 1.53. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52. The stock has a 50 day moving average of $3.90 and a 200-day moving average of $4.78. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics (NASDAQ:CDLXGet Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. The company had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The company’s quarterly revenue was down 15.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.26) EPS. On average, equities research analysts anticipate that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. Finally, Evercore ISI assumed coverage on Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $6.92.

View Our Latest Analysis on CDLX

Hedge Funds Weigh In On Cardlytics

Institutional investors have recently bought and sold shares of the business. Atom Investors LP acquired a new stake in shares of Cardlytics in the third quarter valued at approximately $33,000. SG Americas Securities LLC acquired a new stake in Cardlytics during the 3rd quarter valued at $45,000. Intech Investment Management LLC bought a new position in Cardlytics during the third quarter worth $47,000. Quadrature Capital Ltd acquired a new position in shares of Cardlytics in the third quarter valued at $63,000. Finally, BNP Paribas Financial Markets raised its position in shares of Cardlytics by 32.1% in the third quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock valued at $63,000 after purchasing an additional 4,796 shares during the period. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.